The recent surge in cases of coronavirus disease 2019 alarms public health officials; the FDA launches a new cancer clinical trial program; the Federal Communications Commission may change its National Suicide Prevention Hotline number.
In an appearance before the House Energy and Commerce Committee yesterday, Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, and other public health officials warned that the coronavirus disease 2019 (COVID-19) pandemic will get worse as the country continues to reopen, unless new restrictions are put in place, reports The Washington Post. Their testimony follows comments from President Donald Trump that he asked for testing to slow so the number of cases would appear smaller. Along with Fauci, CDC Director Robert R. Redfield, MD; FDA Commissioner Stephen M. Hahn, MD; and HHS Assistant Secretary for Health Brett P. Giroir, MD, all said they had not been asked to reduce the testing rate, with Giroir stressing the need for more funding. Just yesterday, the United States had 33,730 new COVID-19 cases, which is its highest total since April 25, and the 4 men testified that the US health care system will likely face an even greater trial in the fall and winter, when the seasonal flu returns.
The FDA has launched Project Patient Voice, from the Oncology Center of Excellence, which will contain patient-reported outcome (PRO) data from cancer clinical trials, according to a press release from the FDA. This information on the adverse effects of treatments received during trials is meant “to better inform treatment choices” for both patients and their health care teams, noted FDA Principal Deputy Commissioner Amy Abernethy, MD, PhD. Eventually the new portal will contain PRO information on numerous trials, but for this pilot, there will be just 1 trial, with the FDA asking for feedback, which it will use to improve the site going forward.
By July 16, the Federal Communications Commission (FCC) intends to vote on a proposed update to its current 10-digit National Suicide Prevention Hotline number, according to a statement from FCC Chairman Ajit Pai. In testimony before the National Council for Behavioral Health, Pai detailed the FCC’s plans to establish “988” as the number for individuals with mental health crises, noting several unfortunate statistics: 48,000 Americans lost to suicide in 2018; a 35% increase in suicides since 1999; and a suicide rate among veterans that is 1.5 times higher than the general population. A 2022 deadline is expected for full implementation, at which time 988 will replace the current hotline number, 1-800-273-8255.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More